Sep 2026
IER5L Facilitates the Progression of Hormone Receptor-Positive Breast Cancer by Inhibiting HSF1 Phosphorylation in Response to Bevacizumab.
Wei Jia, Haoqi Wang, Li-Na Zhang et al.
· Cell Biochemistry and Biophy... · 0 citations